BIT
HPTX

BlackRock Institutional Trust’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock Institutional Trust’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-201,568
Closed -$9.25M – 4044
2015
Q1 		$9.25M Sell
201,568
-9,805
-5% -$293K ﹤0.01% 2440
2014
Q4 		$5.07M Buy
211,373
+73,358
+53% +$1.65M ﹤0.01% 2726
2014
Q3 		$3.48M Sell
138,015
-17,837
-11% -$443K ﹤0.01% 2834
2014
Q2 		$4.07M Sell
155,852
-8,570
-5% -$220K ﹤0.01% 2878
2014
Q1 		$4.24M Buy
164,422
+75,308
+85% +$2.04M ﹤0.01% 2848
2013
Q4 		$1.8M Sell
89,114
-1,854
-2% -$43.6K ﹤0.01% 3207
2013
Q3 		$2.38M Buy
90,968
+5,149
+6% +$129K ﹤0.01% 3040
2013
Q2 		$1.89M Buy
+85,819
New +$1.88M ﹤0.01% 3107

BlackRock Institutional Trust's HPTX Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 201,568 shares — an estimated $9.25M sold.

BlackRock Institutional Trust first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $9.25M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock Institutional Trust reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 201,568 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $9.25M.
  • BlackRock Institutional Trust first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock Institutional Trust's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $9.25M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.